Migraine Clinical Trials in Chicago

Showing 21-40 of 59 trials

A Study on the Usability of the Needle-free Intraject® System in Adult Patients During Acute Migraine Attack

NCT00530517

Intraject is a needle-free, single use, disposable, subcutaneous delivery system pre-filled with 6mg Sumatriptan to be used by patients to treat acute migraine treatment. Study participation will last one month and include 2 doctor visits and 2-4 phone calls.

Migraine Headache

Zogenix, Inc.54 participantsStarted Sep 2007

Chicago, Illinois, United States • Springfield, Missouri, United States • St Louis, Missouri, United States +1 more locations

TERMINATEDPHASE32.2 miles

A Study to Evaluate the Efficacy and Safety of TEV-48125 (Fremanezumab) for the Prevention of Episodic Cluster Headache (ECH)

NCT02945046

This is a 13-week, multicenter, randomized, double-blind, double-dummy, placebo-controlled, parallel-group study to compare the efficacy and safety of 2 dose regimens of TEV-48125 (Fremanezumab) versus placebo in adult participants for the prevention of ECH.

Episodic Cluster Headache

Teva Branded Pharmaceutical Products R&D, Inc.169 participantsStarted Jan 2017

Phoenix, Arizona, United States • Canoga Park, California, United States • Santa Monica, California, United States +79 more locations

A Study on the Usability of the Needle-free Intraject® System in Adult Patients During Acute Migraine Attack

A Study to Evaluate the Efficacy and Safety of TEV-48125 (Fremanezumab) for the Prevention of Episodic Cluster Headache (ECH)

Migraine Trials in Other Cities

A Study Comparing the Efficacy and Safety of Fremanezumab (TEV-48125) for the Prevention of Chronic Cluster Headache (CCH)

Safety and Efficacy of NPS 1776 in the Acute Treatment of Migraine Headaches

Occipital Nerve Stimulation (ONS) for Migraine: OPTIMISE

Study in Participants With Acute Migraines Headaches

An Extension Study to Evaluate the Long-Term Safety and Tolerability of Ubrogepant in the Treatment of Migraine

Efficacy, Safety, and Tolerability of Oral Ubrogepant in the Acute Treatment of Migraine

ESCAPE Migraine Trial

Efficacy, Tolerability, and Safety of DFN-15

Efficacy, Safety, and Tolerability of Multiple Dosing Regimens of Oral Atogepant (AGN-241689) in Episodic Migraine Prevention

Efficacy and Safety of Eletriptan for the Treatment of Migraine in Patients Not Satisfied With Rizatriptan Therapy

A Study to Evaluate the Efficacy and Safety of Erenumab (AMG 334) in Chronic Migraine Prevention

A Study of Galcanezumab (LY2951742) in Participants With Migraine Headache

Study To Assess Adverse Events and Drug to Drug Interaction of Oral Tablet Atogepant and Ubrogepant in Adult Participants With a History of Migraine

Effect of Erenumab-aooe on Disability and Work Productivity in Employed Subjects With Episodic Migraine

A Study of Galcanezumab (LY2951742) in Adults With Treatment-Resistant Migraine

Non-Invasive Neurostimulation for the Prevention of Chronic Migraine

A Safety Study of Galcanezumab in Participants With Migraine, With or Without Aura

Use of the Avulux® Lenses as an Aid in Reducing the Impact of Migraine Headaches

Other Conditions in Chicago